breast cancer - triple negative | |||
la/mBC - TNBC - L2 - all population | la/mBC - TNBC - L2 - PDL1 positive | es-BC - TNBC - NA - all population | |
atezolizumab plus SoC | IMpassion-132, ITT population | IMpassion-132, PD-L1 positive population | NeoTrip Michel Angelo IMpassion-031 ... ALEXANDRA/IMpassion-030 |
Study type:
delta: difference in rate or median (if available)
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-